It is important to note that patients who fail to meet all of these risk factors (i.e., patients on stable doses without gastrointestinal symptoms) can still have delayed gastric emptying
The mechanism is gentler on the cardiovascular system compared to stimulant medications, making it suitable for a broader range of patients, including those with metabolic conditions
A: Yes, Mounjaro can be prescribed for weight management in adults with obesity, regardless of whether they have type 2 diabetes, as long as they meet the necessary health criteria
It's a risky option
The class of drugs, known as GLP-1 agonists, have been found to offer dramatic benefits to heart patients, significantly cutting their risk of falling seriously ill or dying prematurely from any cause
10.1001/jama.2021.1831 33